Royal Bank of Canada’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,740
Closed -$817K 7401
2024
Q3
$817K Buy
11,740
+3,982
+51% +$273K ﹤0.01% 3708
2024
Q2
$522K Buy
7,758
+338
+5% +$22.8K ﹤0.01% 3985
2024
Q1
$512K Sell
7,420
-13,615
-65% -$919K ﹤0.01% 3959
2023
Q4
$1.31M Buy
21,035
+14,465
+220% +$809K ﹤0.01% 3447
2023
Q3
$368K Sell
6,570
-19,605
-75% -$1.1M ﹤0.01% 4288
2023
Q2
$1.32M Sell
26,175
-3,264
-11% -$174K ﹤0.01% 3154
2023
Q1
$1.61M Buy
29,439
+2,175
+8% +$127K ﹤0.01% 2973
2022
Q4
$1.71M Buy
27,264
+6,626
+32% +$440K ﹤0.01% 3041
2022
Q3
$1.45M Buy
20,638
+18,765
+1,002% +$1.29M ﹤0.01% 3119
2022
Q2
$106K Sell
1,873
-14,693
-89% -$806K ﹤0.01% 5294
2022
Q1
$1.04M Sell
16,566
-7,330
-31% -$395K ﹤0.01% 3607
2021
Q4
$1.34M Sell
23,896
-3,632
-13% -$222K ﹤0.01% 3533
2021
Q3
$1.79M Sell
27,528
-1,540
-5% -$105K ﹤0.01% 3161
2021
Q2
$1.84M Buy
29,068
+15,500
+114% +$915K ﹤0.01% 3137
2021
Q1
$813K Buy
13,568
+1,043
+8% +$56.7K ﹤0.01% 3774
2020
Q4
$625K Buy
12,525
+2,471
+25% +$116K ﹤0.01% 3942
2020
Q3
$514K Buy
10,054
+2,195
+28% +$91.6K ﹤0.01% 3826
2020
Q2
$276K Sell
7,859
-1,389
-15% -$47.8K ﹤0.01% 4216
2020
Q1
$235K Buy
9,248
+41
+0.4% +$1.22K ﹤0.01% 4211
2019
Q4
$255K Buy
9,207
+1,452
+19% +$34.7K ﹤0.01% 4472
2019
Q3
$209K Buy
7,755
+1,225
+19% +$42.7K ﹤0.01% 4417
2019
Q2
$268K Buy
6,530
+4,530
+227% +$127K ﹤0.01% 4279
2019
Q1
$48K Buy
+2,000
New +$36.3K ﹤0.01% 5185

Other funds holding AXNX

Royal Bank of Canada's AXNX Position: Q4 2024 in Review

Royal Bank of Canada sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 11,740 shares — an estimated $817K sold.

Royal Bank of Canada first reported a position in AXNX in Q1 2019 and held it in 23 quarters. The position peaked at $1.84M in Q2 2021. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Royal Bank of Canada reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 11,740 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $817K.
  • Royal Bank of Canada first reported a position in Axonics, Inc. Common Stock in Q1 2019 and held it in 23 quarters.
  • Royal Bank of Canada's Axonics, Inc. Common Stock position peaked at $1.84M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.